Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women

Clinical Microbiology and Infection

Volumn 21, Issue 6, 2015, Pages 568.e13-568.e21

  Kwatra, G ^a   Adrian, P V ^a   Shiri, T ^a   Buchmann, E J ^a   Cutland, C L ^a   Madhi, S A ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

Antibody; Colonization; Group B Streptococcus; Opsonophagocytic activity; Pregnant women

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; HUMORAL IMMUNITY; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SEROTYPING; BACTERIAL CAPSULE; BLOOD; CLASSIFICATION; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LATEX AGGLUTINATION TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; PHAGOCYTOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; RECTUM; SEROTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA; YOUNG ADULT;

STREPTOCOCCUS SP. 'GROUP B';

ADULT; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INFANT, NEWBORN; LATEX FIXATION TESTS; PHAGOCYTOSIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECTUM; SEROGROUP; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA; YOUNG ADULT;

EID: 84930792320     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.01.030     Document Type: Article

References (34)

1. Verani J.R., McGee L., Schrag S.J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Morb Mortal Wkly Rep 2010, 59:1-36.
2. Chan SHS W.K., Lee W.H. Review on group B streptococcal infection. HK J Paediatr (New Series) 2000, 5:8.
3. Beal S., Dancer S. Antenatal prevention of neonatal group B streptococcal infection. Rev Gynaecol Perinatal Pract 2006, 6:218-225.
4. Heath P.T., Feldman R.G. Vaccination against group B Streptococcus. Expert Rev Vaccines 2005, 4:207-218.
5. Edwards M.S., Gonik B. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine 2013, 31(Suppl.4):D66-D71.
6. Schrag S.J., Schuchat A. Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention. Clin Infect Dis 2004, 38:1209-1211.
7. Colbourn T., Asseburg C., Bojke L., Philips Z., Claxton K., Ades A.E., et al. Prenatal screening andtreatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expectedvalue of information analyses. Health Technol Assess 2007, 11. 1-226, III.
8. Schrag S.J. Group B streptococcal vaccine for resource-poor countries. Lancet 2011, 378:11-12.
9. Robbins J.B., Schneerson R., Vann W.F., Bryla D.A., Fattom A. Prevention of systemic infections caused by group B Streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann N Y Acad Sci 1995, 754:68-82.
10. Baker C.J., Edwards M.S., Kasper D.L. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981, 68:544-549.
11. Baker C.J., Carey V.J., Rench M.A., Edwards M.S., Hillier S.L., Kasper D.L., et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. JInfect Dis 2014, 209:781-788.
12. Lin F.Y., Weisman L.E., Azimi P.H., et al. Level of maternal IgG anti-group B Streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. JInfect Dis 2004, 190:928-934.
13. Hansen S.M., Uldbjerg N., Kilian M., Sorensen U.B. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. JClin Microbiol 2004, 42:83-89.
14. Goodman J.R., Berg R.L., Gribble R.K., Meier P.R., Fee S.C., Mitchell P.D. Longitudinal study of group B Streptococcus carriage in pregnancy. Infect Dis Obstet Gynecol 1997, 5:237-243.
15. Campbell J.R., Hillier S.L., Krohn M.A., Ferrieri P., Zaleznik D.F., Baker C.J. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000, 96:498-503.
16. Davies H.D., Adair C., McGeer A., Ma D., Robertson S., Mucenski M., et al. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. JInfect Dis 2001, 184:285-291.
17. Anthony B.F., Concepcion N.F., Wass C.A., Heiner D.C. Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci. Infect Immun 1984, 46:98-104.
18. Matsubara K., Katayama K., Baba K., Nigami H., Harigaya H. Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan. Eur J Clin Microbiol Infect Dis 2003, 22:453-454.
19. Matsubara K., Katayama K., Baba K., Nigami H., Harigaya H., Sugiyama M. Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan. JInfect Dis 2002, 186:855-858.
20. Skidmore A.G., Henry D.A., Smith A. Prevalence of type-specific group B streptococcal antibody in human sera: a study of 405 pregnant women. Am J Obstet Gynecol 1985, 152:857-860.
21. Baker C.J., Webb B.J., Kasper D.L., Yow M.D., Beachler C.W. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus. Am J Obstet Gynecol 1980, 137:39-42.
22. Beachler C.W., Baker C.J., Kasper D.L., Fleming D.K., Webb B.J., Yow M.D. Group B streptococcal colonization and antibody status in lower socioeconomic parturient women. Am J Obstet Gynecol 1979, 133:171-173.
23. Kwatra G., Madhi S.A., Cutland C.L., Buchmann E.J., Adrian P.V. Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B Streptococcus in vaginal and rectal swabs from pregnant women in South Africa. JClin Microbiol 2013, 51:2515-2519.
24. Afshar B., Broughton K., Creti R., Decheva A., Hufnagel M., Kriz P., et al. International external quality assurance for laboratory identification and typing of Streptococcus agalactiae (group B streptococci). JClin Microbiol 2011, 49:1475-1482.
25. Poyart C., Tazi A., Reglier-Poupet H., Billoet A., Tavares N., Raymond J., et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. JClin Microbiol 2007, 45:1985-1988.
26. Schlottmann S.A., Jain N., Chirmule N., Esser M.T. Anovel chemistry for conjugating pneumococcal polysaccharides to luminex microspheres. JImmunol Methods 2006, 309:75-85.
27. Michon F., Uitz C., Sarkar A., et al. Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity. Clin Vaccine Immunol 2006, 13:936-943.
28. Ferrieri P., Hillier S.L., Krohn M.A., Moore D., Paoletti L.C., Flores A.E. Characterization of vaginal and rectal colonization with multiple serotypes of group B streptococci using multiple colony picks. Indian J Med Res 2004, 119(Suppl.l):208-212.
29. Kwatra G., Adrian P.V., Shiri T., Buchmann E.J., Cutland C.L., Madhi S.A. Serotype-specific acquisition and loss of group B Streptococcus recto-vaginal colonization in late pregnancy. PLoS One 2014, 9:e98778.
30. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type B. JInfect Dis 1995, 171:93-98.
31. Dagan R., Givon-Lavi N., Fraser D., Lipsitch M., Siber G.R., Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. JInfect Dis 2005, 192:367-376.
32. Maiden M.C., Stuart J.M. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 2002, 359:1829-1831.
33. Simell B., Nurkka A., Ekstrom N., Givon-Lavi N., Kayhty H., Dagan R. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol 2012, 19:1618-1623.
34. Madhi S.A., Dangor Z., Heath P.T., Schrag S., Izu A., Sobanjo-Ter Meulen A., et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine 2013, 31(Suppl.4):D52-D57.